[Federal Register Volume 81, Number 108 (Monday, June 6, 2016)]
[Notices]
[Page 36282]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13247]



[[Page 36282]]

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID: DoD-2015-HA-0119]


Submission for OMB Review; Comment Request

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Defense has submitted to OMB for clearance, 
the following proposal for collection of information under the 
provisions of the Paperwork Reduction Act.

DATES: Consideration will be given to all comments received by July 6, 
2016.

FOR FURTHER INFORMATION CONTACT: Fred Licari, 571-372-0493.

SUPPLEMENTARY INFORMATION: 
    Title, Associated Form and OMB Number: Federal Agency Retail 
Pharmacy Program; OMB Control Number 0720-0032.
    Type of Request: Extension of a currently approved collection.
    Number of Respondents: 300.
    Responses Per Respondent: 4.
    Annual Responses: 1200.
    Average Burden Per Response: 8 hours.
    Annual Burden Hours: 9600.
    Needs and Uses: The Department of Defense (DoD) is extending the 
information collection requirements under current OMB Control Number 
0720-0032. Specifically, under the collection of information, 
pharmaceutical manufacturers will base refund calculation reporting 
requirements on the difference between the average non-Federal price of 
the drug sold by the pharmaceutical manufacturer to wholesalers, as 
represented by the most recent annual non-Federal average manufacturing 
prices (non-FAMP) (reported to the Department of Veterans Affairs (VA)) 
and the corresponding Federal Ceiling Price (FCP) or, in the discretion 
of the pharmaceutical manufacturer, the difference between the FCP and 
direct commercial contract sales prices specifically attributable to 
the reported TRICARE paid pharmaceuticals determined for each 
applicable National Drug Code (NDC) listing, per Refund Procedures 
outlined in CFR 199.21. DoD will use the reporting and audit 
capabilities of the Pharmacy Data Transaction Service (PDTS) to 
validate refunds owed to the Government. In Fiscal Year (FY) 15, the 
government received approximately $1.1 billion from pharmaceutical 
manufacturers as a result of this program/refund calculation reporting 
requirements.
    Affected Public: Business or other for-profit.
    Frequency: Quarterly.
    Respondent's Obligation: Mandatory.
    OMB Desk Officer: Ms. Stephanie Tatham.
    Comments and recommendations on the proposed information collection 
should be emailed to Ms. Stephanie Tatham, DoD Desk Officer, at 
[email protected]. Please identify the proposed information 
collection by DoD Desk Officer and the Docket ID number and title of 
the information collection.
    You may also submit comments and recommendations, identified by 
Docket ID number and title, by the following method:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
    Instructions: All submissions received must include the agency 
name, Docket ID number and title for this Federal Register document. 
The general policy for comments and other submissions from members of 
the public is to make these submissions available for public viewing on 
the Internet at http://www.regulations.gov as they are received without 
change, including any personal identifiers or contact information.
    DOD Clearance Officer: Mr. Frederick Licari.
    Written requests for copies of the information collection proposal 
should be sent to Mr. Licari at WHS/ESD Directives Division, 4800 Mark 
Center Drive, East Tower, Suite 02G09, Alexandria, VA 22350-3100.

    Dated: June 1, 2016.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2016-13247 Filed 6-3-16; 8:45 am]
 BILLING CODE 5001-06-P